125 related articles for article (PubMed ID: 8183909)
1. E-cadherin distribution in interleukin 6-induced cell-cell separation of ductal breast carcinoma cells.
Tamm I; Cardinale I; Kikuchi T; Krueger JG
Proc Natl Acad Sci U S A; 1994 May; 91(10):4338-42. PubMed ID: 8183909
[TBL] [Abstract][Full Text] [Related]
2. Cell-adhesion-disrupting action of interleukin 6 in human ductal breast carcinoma cells.
Tamm I; Kikuchi T; Cardinale I; Krueger JG
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3329-33. PubMed ID: 7512730
[TBL] [Abstract][Full Text] [Related]
3. The effects of IL-6 on cell adhesion and e-cadherin expression in breast cancer.
Asgeirsson KS; Olafsdóttir K; Jónasson JG; Ogmundsdóttir HM
Cytokine; 1998 Sep; 10(9):720-8. PubMed ID: 9770334
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells.
Tamm I; Cardinale I; Krueger J; Murphy JS; May LT; Sehgal PB
J Exp Med; 1989 Nov; 170(5):1649-69. PubMed ID: 2553849
[TBL] [Abstract][Full Text] [Related]
5. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
Moll R; Mitze M; Frixen UH; Birchmeier W
Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859
[TBL] [Abstract][Full Text] [Related]
6. Decreased adherence of interleukin 6-treated breast carcinoma cells can lead to separation from neighbors after mitosis.
Tamm I; Cardinale I; Murphy JS
Proc Natl Acad Sci U S A; 1991 May; 88(10):4414-8. PubMed ID: 1852008
[TBL] [Abstract][Full Text] [Related]
7. Ubenimex activates the E-cadherin-mediated adhesion of a breast cancer cell line YMB-S.
Fujioka S; Kohno N; Hiwada K
Jpn J Cancer Res; 1995 Apr; 86(4):368-73. PubMed ID: 7775259
[TBL] [Abstract][Full Text] [Related]
8. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
[TBL] [Abstract][Full Text] [Related]
9. Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.
Harigopal M; Berger AJ; Camp RL; Rimm DL; Kluger HM
Clin Cancer Res; 2005 Jun; 11(11):4083-9. PubMed ID: 15930343
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma.
Wahed A; Connelly J; Reese T
Ann Diagn Pathol; 2002 Dec; 6(6):349-51. PubMed ID: 12478484
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 enhances motility of breast carcinoma cells.
Sehgal PB; Tamm I
EXS; 1991; 59():178-93. PubMed ID: 1655518
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical study of P-cadherin in breast cancer].
Kovács A; Walker RA; Nagy A; Gomba S; Jones L; Dearing S
Orv Hetil; 2002 Feb; 143(8):405-9. PubMed ID: 11921707
[TBL] [Abstract][Full Text] [Related]
13. Immunolocalization of the fodrin, E-cadherin, and beta-catenin adhesion complex in infiltrating ductal carcinoma of the breast-comparison with an in vitro model.
Sormunen RT; Leong AS; Vääräniemi JP; Fernando SS; Eskelinen SM
J Pathol; 1999 Mar; 187(4):416-23. PubMed ID: 10398100
[TBL] [Abstract][Full Text] [Related]
14. [Expression of E-cadherine as a differential diagnostic fest for lobular infiltrative breast cancers].
Chipysheva TA; Ermilova VD; Vishnevskaia IaV; Vasil'ev IuM
Arkh Patol; 2005; 67(6):24-7. PubMed ID: 16405017
[TBL] [Abstract][Full Text] [Related]
15. N-cadherin expression in breast cancer: correlation with an aggressive histologic variant--invasive micropapillary carcinoma.
Nagi C; Guttman M; Jaffer S; Qiao R; Keren R; Triana A; Li M; Godbold J; Bleiweiss IJ; Hazan RB
Breast Cancer Res Treat; 2005 Dec; 94(3):225-35. PubMed ID: 16258702
[TBL] [Abstract][Full Text] [Related]
16. The biological and prognostic significance of cell polarity and E-cadherin in grade I infiltrating ductal carcinoma of the breast.
Tan DS; Potts HW; Leong AC; Gillett CE; Skilton D; Harris WH; Liebmann RD; Hanby AM
J Pathol; 1999 Sep; 189(1):20-7. PubMed ID: 10451483
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of E-cadherin in sclerosing adenosis, ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Facina G; Lopes-Costa PV; Dos Santos AR; De Vasconcelos-Valença RJ; Pinho-Sobral AL; Ferreira-Filho CP; Alencar AP; Gebrim LH; Da Silva BB
Diagn Cytopathol; 2010 Apr; 38(4):235-8. PubMed ID: 19790246
[TBL] [Abstract][Full Text] [Related]
18. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features.
Palacios J; Benito N; Pizarro A; Suárez A; Espada J; Cano A; Gamallo C
Am J Pathol; 1995 Mar; 146(3):605-12. PubMed ID: 7534041
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin expression correlates with histologic type but not tumour grade in invasive breast cancer.
Nurismah MI; Noriah O; Suryati MY; Sharifah NA
Asian Pac J Cancer Prev; 2008; 9(4):699-702. PubMed ID: 19256762
[TBL] [Abstract][Full Text] [Related]
20. Adhesiveness of the apical surface of uterine epithelial cells: the role of junctional complex integrity.
Thie M; Fuchs P; Butz S; Sieckmann F; Hoschützky H; Kemler R; Denker HW
Eur J Cell Biol; 1996 Jul; 70(3):221-32. PubMed ID: 8832206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
